Skip to Main Content

Author Details

Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
1986
384
83
PMIDPaper TitleJournal TitlePublished Year
37675516Uniform conditioning regardless of donor in bone marrow transplantation for severe aplastic anemia.Haematologica2024
37675516Uniform conditioning regardless of donor in bone marrow transplantation for severe aplastic anemia.Haematologica2024
35908981The next horizon now that everyone has a donor: Precision allogeneic transplantation.Blood Rev2023
35908981The next horizon now that everyone has a donor: Precision allogeneic transplantation.Blood Rev2023
36435690The development of post-transplant cyclophosphamide: Half a century of translational team science.Blood Rev2023
37662423Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.medRxiv2023
36840972Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.Cancer2023
36519323CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.Haematologica2023
37408464Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.Haematologica2023
37342922Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.N Engl J Med2023
36587740Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age â¿¥55 Years.Transplant Cell Ther2023
37084383Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.Blood2023
37276081Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.Blood Adv2023
37386913A Study of Physical Resilience and Aging (SPRING): Conceptual framework, rationale, and study design.J Am Geriatr Soc2023
36869287Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant.BMC Geriatr2023
36549386Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.Transplant Cell Ther2023
36993719Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.Res Sq2023
37301659PTCy: The "new" standard for GVHD prophylaxis.Blood Rev2023
37662423Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.medRxiv2023
36993719Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.Res Sq2023
37084383Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.Blood2023
37386913A Study of Physical Resilience and Aging (SPRING): Conceptual framework, rationale, and study design.J Am Geriatr Soc2023
37408464Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.Haematologica2023
37342922Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.N Engl J Med2023
37276081Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.Blood Adv2023
37301659PTCy: The "new" standard for GVHD prophylaxis.Blood Rev2023
36549386Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.Transplant Cell Ther2023
36587740Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age â¿¥55 Years.Transplant Cell Ther2023
36519323CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.Haematologica2023
36435690The development of post-transplant cyclophosphamide: Half a century of translational team science.Blood Rev2023
36840972Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.Cancer2023
36869287Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant.BMC Geriatr2023
34775146Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.Transplant Cell Ther2022
35907408Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.Lancet Haematol2022
35379077Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.Leuk Lymphoma2022
35613462HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age.Blood Adv2022
35915978Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.Leuk Lymphoma2022
35663288Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.Open Forum Infect Dis2022
34793200Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.J Clin Oncol2022
34855460Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.J Clin Oncol2022
35244681Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.Blood Adv2022
34663912Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study.Leukemia2022
34775146Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.Transplant Cell Ther2022
34657151Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.Blood2022
35179961The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.Sci Adv2022
35158092Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.Transplant Cell Ther2022
34936931Incidence and Outcomes of Respiratory Failure after Nonmyeloablative Related Haploidentical Blood or Marrow Transplantation.Transplant Cell Ther2022
35343368CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.Leuk Lymphoma2022
34750086Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.Clin Lymphoma Myeloma Leuk2022
35613462HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age.Blood Adv2022
  • 1 - 50 of 768

Recommended Authors

Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 2
Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 4
Yusuke Nakauchi
Institute of Space and Astronautical Science
Career Start Year 2010
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 4
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 2
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 4
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 3
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 1
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 5
Maura Gasparetto
University of Colorado School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 7
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 9
Wendy Hu
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Gabrielle Meyers
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 3
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 1
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 7
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 2
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 10
Koen van Besien
University Hospitals of Cleveland
Career Start Year 1988
Number of shared co-authors 7
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 1
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 9
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 14
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 1
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 3
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 4
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 2
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 14
Wolfgang E Berdel
University Hospital Munster
Career Start Year 1976
Number of shared co-authors 3
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 4

Collaborators

Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 88
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 53
Mark J Levis
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 25
Christopher D Gocke
Johns Hopkins University School of Medicine
Co-authored papers 23
Michelle Petri
Co-authored papers 7
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers 6
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers 6
David M Loeb
Children's Hospital at Montefiore.
Co-authored papers 6
Scott H Kaufmann
Mayo Clinic
Co-authored papers 6
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Co-authored papers 5
Jerry L Spivak
The Johns Hopkins University School of Medicine
Co-authored papers 5
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 4
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 4
Rong Hu
Co-authored papers 4
Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers 3
Nancy E Davidson
Co-authored papers 3
Donald Small
Johns Hopkins University School of Medicine
Co-authored papers 3
Douglas A Kerr
Johns Hopkins University School of Medicine
Co-authored papers 3
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers 3
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 3
Pei Lin
Co-authored papers 2
Shmuel Shoham
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 2
Mark J Ratain
University of Chicago
Co-authored papers 2
Li Li
Johns Hopkins University School of Medicine
Co-authored papers 2
Chi V Dang
Johns Hopkins University School of Medicine
Co-authored papers 2
Eneida R Nemecek
Oregon Health Sciences University
Co-authored papers 2
Vered Stearns
Co-authored papers 2
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Co-authored papers 2
Justin C McArthur
Johns Hopkins School of Medicine
Co-authored papers 2
Joel E Gallant
Co-authored papers 2
Release 1.2